Literature DB >> 11174474

Which women with stress incontinence require urodynamic evaluation?

A C Weidner1, E R Myers, A G Visco, G W Cundiff, R C Bump.   

Abstract

OBJECTIVE: This study was undertaken to determine the predictive value of the symptom of stress urinary incontinence and to evaluate the ability of other factors suggested by a published Agency for Health Care Policy and Research guideline for the discrimination of patients unlikely to require urodynamic testing before surgical management. STUDY
DESIGN: We evaluated 950 consecutive women without advanced (stage III or IV) pelvic organ prolapse who were referred with symptoms of incontinence. Incontinence was recorded by means of standard forms and was characterized as "any stress loss" (76.4%), "primarily stress loss" (58.9%), "stress loss only" (29.8%), "stress and urge loss" (52.2%), "urge loss only" (13.8%), "constant and stress loss" (1.9%), or "constant loss" (2.3%). Other variables were assessed by means of a standardized history, physical examination (including urethral axis determination and stress test), 1-week urinary diary, and postvoid residual volume measurement. A urodynamic diagnosis of pure genuine stress incontinence was used as the criterion standard. Sensitivity, specificity, and positive and negative predictive values were calculated. Logistic regression models incorporating various combinations of stress loss only, previous prolapse or incontinence surgery, nocturia, voiding frequency, urethral hypermobility, and postvoid residual volume <100 mL (the factors recommended by the Agency for Health Care Policy and Research guidelines), along with age and race as predictors of genuine stress incontinence, were constructed to evaluate the predictive ability of the guideline in a subset of 447 patients for whom data on all variables were available.
RESULTS: Of the entire population 480 (50.5%) had pure genuine stress incontinence, 134 (14.1%) had both genuine stress incontinence and detrusor instability, 180 (18.9%) had pure detrusor instability, and 40 (4.2%) had intrinsic sphincter deficiency. Fifty-four (5.7%) had normal study results, and 62 (6.5%) had other nonincontinence diagnoses. Among the subjects with symptoms of stress loss only, 10.8% did not have genuine stress incontinence confirmed on urodynamic examination. Agency for Health Care Policy and Research guideline criteria had excellent discrimination (C statistic of 0.807) compared with the sole criterion of stress urinary incontinence only (C statistic of 0.574), with a positive predictive value of 85.7%. Only 7.8% of subjects met all the criteria, however, and 5.7% of these ultimately had a urodynamic diagnosis of either detrusor instability or normal study result.
CONCLUSION: The predictive value of stress symptoms alone was not high enough to serve as the basis for surgical management. Agency for Health Care Policy and Research guidelines improved the predictive value but were applicable to only a small subset of patients referred with urinary incontinence.

Entities:  

Mesh:

Year:  2001        PMID: 11174474     DOI: 10.1067/mob.2001.108171

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  17 in total

1.  Preoperative clinical, demographic, and urodynamic measures associated with failure to demonstrate urodynamic stress incontinence in women enrolled in two randomized clinical trials of surgery for stress urinary incontinence.

Authors:  Gary E Lemack; Heather J Litman; Charles Nager; Linda Brubaker; Jerry Lowder; Peggy Norton; Larry Sirls; Keith Lloyd; John W Kusek
Journal:  Int Urogynecol J       Date:  2012-06-06       Impact factor: 2.894

Review 2.  Pharmacological management of women with mixed urinary incontinence.

Authors:  Hashim Hashim; Paul Abrams
Journal:  Drugs       Date:  2006       Impact factor: 9.546

Review 3.  Do urodynamic parameters predict persistent postoperative stress incontinence after midurethral sling? A systematic review.

Authors:  Amie Kawasaki; Jennifer M Wu; Cindy L Amundsen; Alison C Weidner; John P Judd; Ethan M Balk; Nazema Y Siddiqui
Journal:  Int Urogynecol J       Date:  2012-03-09       Impact factor: 2.894

Review 4.  The puzzle of overactive bladder: controversies, inconsistencies, and insights.

Authors:  Roger R Dmochowski
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-06-27

5.  Symptomatic stress urinary incontinence not demonstrated clinically: survey of practice patterns.

Authors:  Thaddeus D Mamienski; John R Fischer; Alan Gehrich; Christopher M Zahn
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2008-09-17

6.  The impact of multichannel urodynamics upon treatment recommendations for female urinary incontinence.

Authors:  Renée M Ward; Brittany Star Hampton; Jeffrey D Blume; Vivian W Sung; Charles R Rardin; Deborah L Myers
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2008-04-19

Review 7.  Mixed urinary incontinence: what first?

Authors:  Nazia Q Bandukwala; Angelo E Gousse
Journal:  Curr Urol Rep       Date:  2015-03       Impact factor: 3.092

8.  Can urodynamic stress incontinence be diagnosed by ultrasound?

Authors:  H P Dietz; K Nazemian; K L Shek; A Martin
Journal:  Int Urogynecol J       Date:  2013-01-12       Impact factor: 2.894

9.  Psychometric validation of the Italian version of the I-QoL questionnaire: clinical and urodynamic findings.

Authors:  Federica Possavino; Mario Preti; Roberto Carone; Roberto Calabrese; Sara Randaccio; Chiara D'Elia; Ilaria Allais; Stefano Cosma; Chiara Benedetto
Journal:  Int Urogynecol J       Date:  2013-07-25       Impact factor: 2.894

10.  Effect of duloxetine on tolterodine pharmacokinetics in healthy volunteers.

Authors:  Teng C Hua; Alan Pan; Clark Chan; Yeo K Poo; Michael H Skinner; Mary P Knadler; Celedon R Gonzales; Stephen D Wise
Journal:  Br J Clin Pharmacol       Date:  2004-05       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.